At a glance
ClinicalIndex Comparison RecordN/ACompleted· 33 enrolled
Drug / intervention
Automated Insulin Delivery Settings Initialization and Adaptation Algorithmdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes With AID Use
In Brief
A clinical study evaluating Automated Insulin Delivery Settings Initialization and Adaptation Algorithm for Type 1 Diabetes. Completed, enrolled 33 participants across 1 site.
Detailed Summary
Obtain preliminary safety and performance data on a settings initialization and adaptation algorithm used in conjunction with closed-loop control.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedJan 2022
Enrollment StartMar 2022
Primary CompletionSep 2022
Study CompletionSep 2022
TodayJul 2026
First PostedJan 24, 2022
Enrollment StartMar 24, 2022
Primary CompletionSep 9, 2022
Study CompletionSep 29, 2022
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 4.4 years ago
Interventions
Automated Insulin Delivery Settings Initialization and Adaptation Algorithmdevice
All participants wearing the t:slim X2 insulin pump with Control-IQ technology, and wearing the Dexcom G6 sensor, will have algorithm derived insulin delivery profile settings initialization and updates at regular intervals.